Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Gassan Moady"'
Publikováno v:
Journal of Cardiovascular Pharmacology and Therapeutics, Vol 29 (2024)
Introduction Sodium-glucose cotransporter- 2 (SGLT2) inhibitors have become a cornerstone in heart failure (HF), Type 2 diabetes mellitus (T2DM), and cardiovascular disease (CVD) management. In the current retrospective study, we aimed to assess effi
Externí odkaz:
https://doaj.org/article/3fba686ab83b4da5a28d6a3637005ec3
Publikováno v:
Clinical Medicine Insights: Cardiology, Vol 18 (2024)
Objective: Patients with atrial fibrillation (AF) are at increased risk of thromboembolic events originating mainly from left atrial appendage thrombus (LAAT). Patients with atrial flutter (AFL) are treated with anticoagulation based on the same crit
Externí odkaz:
https://doaj.org/article/a240ec972a0141599ad188d0fb47ac4a
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
BackgroundThe availability of advanced technologies for mechanical support in hospitals with on-site cardiac surgery (CS), along with the ability to perform urgent coronary artery bypass graft (CABG) surgery, may result in improved clinical outcomes
Externí odkaz:
https://doaj.org/article/c3ca13d9768048cabab215966738ba39
Publikováno v:
Cardiovascular Ultrasound, Vol 20, Iss 1, Pp 1-6 (2022)
Abstract Background Despite the inherent limitations of the traditional cardiac physical examination (PE), it has not yet been replaced by a more accurate method. Methods We hypothesized that a single medical student, following a brief training (two
Externí odkaz:
https://doaj.org/article/683c0d1103b74f7697fdac6acd2e64a6
Autor:
Gassan Moady, MD, Shaul Atar, MD
Publikováno v:
CJC Open, Vol 3, Iss 10, Pp 1249-1256 (2021)
The current coronavirus disease 2019 (COVID-19) presents an ongoing medical challenge, as it involves multiple organs, including the cardiovascular system. Takotsubo syndrome (TTS) has been described in the context of COVID-19 in 2 different scenario
Externí odkaz:
https://doaj.org/article/cc210368cc134d2fb0291f2cba498ef7
Publikováno v:
Cardiac Failure Review, Vol 8, Iss , Pp - (2022)
Heart failure (HF) is linked to to high mortality rates and recurrent hospitalisations despite medical and device-based achievements. The use of left ventricular assist devices (LVADs) has improved survival among patients with advanced HF. Significan
Externí odkaz:
https://doaj.org/article/2b81f2b72d3f43ffbfc2d74af97f0b26
Publikováno v:
Biomedicines, Vol 11, Iss 9, p 2337 (2023)
Cardiac hypertrophy develops following different triggers of pressure or volume overload. In several previous studies, different hypertrophy types were demonstrated following alterations in extracellular signal-regulated kinase (ERK) pathway activati
Externí odkaz:
https://doaj.org/article/b323adc360ef4be5b18671166e5f6319
Autor:
Elias Daud, Offir Ertracht, Nadav Bandel, Gassan Moady, Monah Shehadeh, Tali Reuveni, Shaul Atar
Publikováno v:
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-13 (2021)
Abstract Background Myocardial fibrosis is a multistep process, which results in collagen deposition in the injured muscle. Empagliflozin, a sodium-glucose cotransporter 2 inhibitor (SGLT2i), decreases cardiovascular events risk. Little is known on t
Externí odkaz:
https://doaj.org/article/1cdc30ac7c6a45609e6e4ff5f0703c4f
Publikováno v:
Life, Vol 13, Iss 6, p 1256 (2023)
Sodium-glucose co-transporter 2 (SGLT2) inhibitors, originally used for diabetes mellitus, are gaining more popularity for other indications, owing to their positive cardiovascular and renal effects. SGLT2 inhibitors reduce heart failure (HF) hospita
Externí odkaz:
https://doaj.org/article/f6c4856af7a84669a9f413d5b5dac24a
Publikováno v:
Reviews in Cardiovascular Medicine, Vol 23, Iss 4, p 131 (2022)
Takotsubo syndrome is an important condition to consider among patients with acute chest pain in the emergency room. It often mimics acute coronary syndrome since chest pain and ECG changes are key features in both conditions. The hallmark of takotsu
Externí odkaz:
https://doaj.org/article/7e06f1581b99439e9016d6b5a1f2668e